ArticleBMC microbiology2026
First reported Pseudomonas soli bloodstream infection confirmed by whole-genome sequencing after MALDI-TOF misidentification.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo determine the species identity of a rare environmental Pseudomonas isolate recovered from blood culture and to evaluate its antimicrobial resistance profile and pathogenic potential.
methodsThe isolate PS1 was characterized by MALDI-TOF MS identification, antimicrobial susceptibility testing, and whole-genome sequencing. Species assignment was established using average nucleotide identity (ANI) analysis and core-genome phylogenetic analysis. Virulence- and resistance-associated genes were annotated using multiple databases. Phenotypic validation was performed through biofilm formation, serum killing, chrome azurol S (CAS) iron acquisition assay, and the Galleria mellonella infection model.
resultsMALDI-TOF MS misidentified PS1 as Pseudomonas putida, whereas WGS confirmed it as P. soli, showing an ANI value of 99.0536% with P. soli ASM49897v2. PS1 was resistant to some β-lactams and trimethoprim-sulfamethoxazole, but remained generally susceptible to carbapenems, aminoglycosides, and quinolones. Genomic analysis identified virulence-associated modules involved in alginate biosynthesis, iron acquisition, secretion systems, and surface structure remodeling. Phenotypic assays demonstrated that PS1 had strong biofilm-forming ability (OD₅₇₀ = 0.210 ± 0.042) and iron acquisition capacity (CAS halo diameter, 8.63 ± 0.38 mm), showed a certain degree of survival in normal human serum, and exhibited dose-dependent lethality in the Galleria mellonella model.
conclusionThis study reports the first case of bloodstream infection caused by P. soli confirmed by whole-genome sequencing. PS1 harbored multiple virulence‑related genetic modules and exhibited corresponding pathogenic phenotypes. These findings support that P. soli may have opportunistic pathogenic potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.